Top compounds associated with response to SRI


Feature Type Standardized
Nominal ANOVA
mRNA Bortezomib gCSI pan-cancer AAC 0.07 0.2
mRNA Roscovitine FIMM pan-cancer AAC 0.19 0.2
mRNA KIN001-236 GDSC1000 pan-cancer AAC -0.039 0.3
mRNA KIN001-135 GDSC1000 pan-cancer AAC -0.063 0.3
mRNA Tamoxifen CTRPv2 pan-cancer AAC -0.044 0.3
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.044 0.3
mRNA Nutlin-3 CTRPv2 pan-cancer AAC -0.04 0.3
mRNA pifithrin-mu CTRPv2 pan-cancer AAC -0.04 0.3
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.04 0.3
mRNA BRD-K99006945 CTRPv2 pan-cancer AAC 0.06 0.3
Download CSV